Expression of C-erbB-2 and Ki-67 in thyroid tumor and its clinical significance
Liu Yan-l
Abstract
Liu Yan-l
Abstract
Objective To investigate the expression of C-erbB-2 and anti-nuclear antigen Ki-67 in thyroid tumor, and its significance in pathologic diagnosis and prognosis the patient. Methods SP immunohistochemical technique was used to detect the expression of C-erbB-2 and Ki-67 in thyroid tissue of 90 cases of thyroid carcinoma and 20 cases of thyroid adenoma. Results High expression of both C-erbB-2 and Ki-67 in thyroid carcinoma, and their expression was weak in thyroid adenoma. The positive rate of C-erbB-2 expression in thyroid carcinoma was statistically higher than that in thyroid adenoma (48.9% vs 20.0%, P0.05). The proliferation index (LI) of Ki-67 in thyroid carcinoma was notably higher than that in thyroid adenoma ( 44.0±39.3 vs 16.8±17.2, P0.05). There was positive correlation between expressions of C-erbB-2 and Ki-67 (r=0.81, P0.01). Conclusions Strong expression of C-erbB-2 and Ki-67 in thyroid carcinoma implies that C-erbB-2 and Ki-67 may play important roles in the development of thyroid carcinoma. The detection of C-erbB-2 and Ki-67 expression may be useful for the differentiatial diagnosis and prognosis evaluation of thyroid carcinoma and thyroid adenoma.[HS(2*2/3]
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the expression of C-erbB-2 and anti-nuclear antigen Ki-67 in thyroid tumor, and its significance in pathologic diagnosis and prognosis the patient. Methods SP immunohistochemical technique was used to detect the expression of C-erbB-2 and Ki-67 in thyroid tissue of 90 cases of thyroid carcinoma and 20 cases of thyroid adenoma. Results High expression of both C-erbB-2 and Ki-67 in thyroid carcinoma, and their expression was weak in thyroid adenoma. The positive rate of C-erbB-2 expression in thyroid carcinoma was statistically higher than that in thyroid adenoma (48.9% vs 20.0%, P0.05). The proliferation index (LI) of Ki-67 in thyroid carcinoma was notably higher than that in thyroid adenoma ( 44.0±39.3 vs 16.8±17.2, P0.05). There was positive correlation between expressions of C-erbB-2 and Ki-67 (r=0.81, P0.01). Conclusions Strong expression of C-erbB-2 and Ki-67 in thyroid carcinoma implies that C-erbB-2 and Ki-67 may play important roles in the development of thyroid carcinoma. The detection of C-erbB-2 and Ki-67 expression may be useful for the differentiatial diagnosis and prognosis evaluation of thyroid carcinoma and thyroid adenoma.[HS(2*2/3]
Key concepts: Thyroid, Thyroid adenoma, Thyroid carcinoma, Ki-67, Medicine, Adenoma, Immunohistochemistry, Pathology